The HrC Test Logo

Brain Cancer Early Detection and Diagnosis

Brain Cancer – Early Detection and Diagnosis

The Brain Tumour Charity recently launched their new policy report “Brain Tumours: Fighting for Faster Diagnosis”.

This is a well written document that highlights some of the problems faced by patients in obtaining a diagnosis for Brain Cancer:

“Our Improving Brain Tumour Care surveys showed that over one in seven (15%) of the respondents took over six months to get a diagnosis from first seeing a healthcare professional for their symptoms, with one in 10 (10%) waiting over a year to be diagnosed”.

To speed up the detection and diagnosis of Brain Cancer, healthcare professionals need to have far better diagnostic tools at their disposal than what they currently have available to them. There needs to be  a quick and simple way of ruling cancer in or out as a cause of illness.

Now, due to a remarkable breakthrough in cancer diagnostics made by a team of scientists in India, this may be about to change as, for the first time, we can contemplate the prospect of having one single blood test, The HrC Test, to detect every type of cancer, earlier than any other known technology.

Blood flows through every organ in the body. On its journey it collects vital information from each one of those organs, including the Brain. This information from blood is paramount in detecting early-stage cancer. The HrC Test has been developed to target an array of biomarkers that are always present in blood. To what degree they are present is what determines if cancer is absent or present.

Therefore, if healthcare professionals had such a diagnostic tool at their disposal, they could quickly rule cancer in or out as a cause of illness. If cancer is absent, then the healthcare professional can focus their attention on other possible causes of illness. If cancer is present, then the healthcare professional would be able to request that a patient’s blood sample be further processed as to identify:

  • Cancer Type(s) & Sub-Type(s)
  • Pinpoint Location of Tumour(s)
  • Stage of Disease
  • Primary Organ
  • Secondary Organ (if any)
  • Next Organ to be Impacted (if any)
  • Genetic – Mutations, Altered Expressions and Dysregulated Pathways


This information is normally only obtainable from tissue biopsy, we can obtain this same information from a blood sample. This means that any type of cancer can be quicky detected and diagnosed within two to three weeks of a patient’s first visit to their healthcare professional. A win-win situation for all parties.